Oxford Square Capital Corp. (NASDAQ:OXSQ – Get Free Report) announced a monthly dividend on Wednesday, August 14th,Wall Street Journal reports. Shareholders of record on Friday, November 15th will be given a dividend of 0.035 per share on Friday, November 29th. This represents a $0.42 annualized dividend and a yield of 15.00%. The ex-dividend date of this dividend is Friday, November 15th.
Oxford Square Capital has decreased its dividend payment by an average of 6.3% per year over the last three years. Oxford Square Capital has a payout ratio of 116.7% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Research analysts expect Oxford Square Capital to earn $0.28 per share next year, which means the company may not be able to cover its $0.42 annual dividend with an expected future payout ratio of 150.0%.
Oxford Square Capital Stock Performance
NASDAQ:OXSQ opened at $2.80 on Thursday. The firm has a market capitalization of $190.10 million, a PE ratio of -28.00 and a beta of 1.10. The stock has a 50-day simple moving average of $2.88 and a two-hundred day simple moving average of $2.98. Oxford Square Capital has a 52-week low of $2.74 and a 52-week high of $3.29.
Wall Street Analyst Weigh In
Separately, StockNews.com lowered Oxford Square Capital from a “hold” rating to a “sell” rating in a research note on Monday.
Check Out Our Latest Research Report on Oxford Square Capital
Oxford Square Capital Company Profile
Oxford Square Capital Corp. is a business development company, operates as a closed-end, non-diversified management investment company. It is a private equity and mezzanine firm. The firm invests in both public and private companies. It invests in secured and unsecured senior debt, subordinated debt, junior subordinated debt, preferred stock, common stock and syndicated bank loans.
Read More
- Five stocks we like better than Oxford Square Capital
- What Are Some of the Best Large-Cap Stocks to Buy?
- Can United States Cellular Ride Higher on Its Spectrum Strategy?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- HubSpot’s Growth in CRM: Can It Compete With Salesforce?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?”
Receive News & Ratings for Oxford Square Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Square Capital and related companies with MarketBeat.com's FREE daily email newsletter.